跳至主要内容
临床试验/JPRN-UMIN000010858
JPRN-UMIN000010858已完成未知

The efficacy of remifentanil on the BIS values of patients who are treated with mECT:open-labeled single center non-randomized cross-over trial - The efficacy of remifentanil on the BIS values of patients who are treated with mECT

Tokyo Metropolitan Health and Medical Treatment Corporation Toshima Hospital. Department of Anesthesia.0 个研究点目标入组 18 人开始时间: 2013年6月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • ASA PS 4 or 5 history of ischemic heart disease history of heart disease as harmful as ischemic disease allergies or contraindications to medications used in the trial

研究者

发起方
Tokyo Metropolitan Health and Medical Treatment Corporation Toshima Hospital. Department of Anesthesia.

相似试验